Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
The inducible T-REx system and other inducible expression systems have been developed in order to control the expression levels of recombinant protein in mammalian cells. In order to study the effects of heterologous protein expression on mammalian host behavior, the gene for recombinant Human transferrin (hTf) was integrated into HEK-293 cells and expressed under the control of the T-REx inducible technology (293-TetR-Hyg-hTf) or using a constitutive promoter (293-CMV-hTf). A number of inducible clones with variable expression levels were identified for the T-REx system with levels of hTf for the high expressing clones nearly double those obtained using the constitutive cytomegalovirus (CMV) promoter. The level of transferrin produced was found to increase proportionately with tetracycline concentration between 0 and 1 mug/mL with no significant increases in transferrin production above 1 mug/mL. As a result, the optimal induction time and tetracycline concentrations were determined to be the day of plating and 1 mug/mL, respectively. Interestingly, the cells induced to express transferrin, 293-TetR-Hyg-hTf, exhibited lower viable cell densities and percent viabilities than the uninduced cultures for multiple clonal isolates. In addition, the induction of transferrin expression was found to cause an increase in the expression of the ER-stress gene, BiP, that was not observed in the uninduced cells. However, both uninduced and induced cell lines containing the hTf gene exhibited longer survival in culture than the control cells, possibly as a result of the positive effects of hTf on cell survival. Taken together, these results suggest that the high level expression of complex proteins in mammalian cells can limit the viable cell densities of cells in culture as a result of cellular stresses caused by generating proteins that may be difficult to fold or are otherwise toxic to cells. The application of inducible systems such as the T-REx technology will allow us to optimize protein production while limiting the negative effects that result from these cellular stresses.
Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Jullian
J
Jones
Tarangsri
T
Nivitchanyong
Christina
C
Giblin
Valentina
V
Ciccarone
David
D
Judd
Stephen
S
Gorfien
Sharon S
SS
Krag
Michael J
MJ
Betenbaugh
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics; D001483:Base Sequence; D018929:Cell Culture Techniques; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003587:Cytomegalovirus / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D008322:Mammals; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D015202:Protein Engineering / Q000379:methods*; D011994:Recombinant Proteins / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D013752:Tetracycline / Q000494:pharmacology*; D013997:Time Factors; D015534:Trans-Activators / Q000235:genetics; D014168:Transferrin / Q000187:drug effects / Q000235:genetics / Q000378:metabolism
D001426:Bacterial Proteins; D018832:Molecular Chaperones; D011994:Recombinant Proteins; C116102:TetR protein, Clostridium tetani; D015534:Trans-Activators; D014168:Transferrin; D013752:Tetracycline